13FRHYTHM PHARMACEUTICALS INC (RYTM)
6 tracked managers currently hold RYTM on their latest filing. Change is versus that manager’s previous filing. Reported as of quarter end, filed up to ~45 days later, not live positions.
Sort: Size Weight change
Sorted by reported value on the latest filing.
| Manager | Period | Change | Value | Weight | Prev weight | Shares | Δ shares |
|---|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | Q2 2026 | TRIM | $140.3M | 0.1 % | 0.1 % | 1,263,652 | -154,967 |
| Point72 Asset Management, L.P. | Q2 2026 | TRIM | $46.0M | 0.1 % | 0.1 % | 414,210 | -432,591 |
| MILLENNIUM MANAGEMENT LLC | Q2 2026 | TRIM | $35.2M | 0.0 % | 0.0 % | 316,719 | -135,106 |
| Duquesne Family Office LLC | Q2 2026 | NEW | $22.6M | 0.5 % | — | 203,618 | NEW |
| D. E. Shaw & Co., Inc. | Q2 2026 | TRIM | $3.3M | 0.0 % | 0.0 % | 30,168 | -2,484 |
| TWO SIGMA INVESTMENTS, LP | Q2 2026 | ADD | $510.7K | 0.0 % | 0.0 % | 4,600 | +300 |